Position in VCEL
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$300,485
+$83,209 QoQ
Shares Held
6,754
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#47
of 91 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Verdence Capital Advisors LLC holds $3,978,199 across 8 Biotechnology names. VCEL ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
14,342 | $1,013,262 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
12,488 | $977,435 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,901 | $944,283 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
954 | $594,857 | |
| 5 | VCEL |
Vericel Corp
This page
|
6,754 | $300,485 | |
| 6 | ATAI |
AtaiBeckley Inc.
|
19,251 | $101,452 | |
| 7 | OCGN |
Ocugen, Inc.
|
26,500 | $40,545 | |
| 8 | GTBP |
GT Biopharma, Inc.
|
12,000 | $5,880 |
All Filings in VCEL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $300,485 | 6,754 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $217,276 | 6,754 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $243,067 | 6,750 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $212,422 | 6,750 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $287,212 | 6,750 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $301,185 | 6,750 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $370,642 | 6,750 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $285,187 | 6,750 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $309,690 | 6,750 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $351,135 | 6,750 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $240,367 | 6,750 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $226,260 | 6,750 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $253,597 | 6,750 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $216,616 | 7,388 | Shares | Sole | 2023-04-24 | |
| 2022-03-31 | $282,369 | 7,388 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $290,348 | 7,388 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $360,534 | 7,388 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $387,870 | 7,388 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $410,403 | 7,388 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $228,141 | 7,388 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $303,669 | 16,388 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $226,482 | 16,388 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $150,277 | 16,388 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||